ConferenceRes Pract Thromb Haemost · March 2024
The University of North Carolina Symposia on Hemostasis began in 2002, with The First Symposium on Hemostasis with a Special Focus on FVIIa and Tissue Factor. They have occurred biannually since and have maintained the primary goal of establishing a forum ...
Full textLink to itemCite
ConferenceBlood · December 2, 2016
AbstractThe mechanisms underlying the PF4/heparin immune response are poorly understood. In recent studies, we showed that PF4/heparin complexes, but not PF4 alone or heparin alone, activate complement (C') ...
Full textCite
ConferenceBlood · December 2, 2016
AbstractThe immune response to platelet factor 4 (PF4)/heparin complexes is a frequent iatrogenic complication of heparin therapy associated with development of heparin-induced thrombocytopenia (HIT). Our re ...
Full textCite
ConferenceBlood · December 2, 2016
AbstractDespite notable disadvantages, unfractionated heparin (UFH) remains the standard anticoagulant for clinical procedures requiring potent and reversible anticoagulation such as cardiopulmonary bypass ( ...
Full textCite
ConferenceBlood · December 3, 2015
AbstractThe thrombotic microangiopathies (TMAs) are rare, life-threatening thrombotic disorders of diverse etiologies. Systematic studies of TMA have been difficult to perform due to their rare occurrence, d ...
Full textCite
ConferenceBlood · December 3, 2015
AbstractProtamine/heparin (PRT/H) antibodies (Abs) are a newly described class of heparin-dependent antibodies found in ~25% of patients exposed to protamine and heparin during cardiopulmonary bypass surgery ...
Full textCite
ConferenceBlood · December 6, 2014
AbstractBackground:Screening for deficiency of ADAMTS- 13, a von Willebrand factor-cleaving protease, is commonly performed when there exists a clinical suspicion for thrombo ...
Full textCite
ConferenceBlood · December 6, 2014
AbstractProtamine/heparin (PRT/H) antibodies (Ab) are a newly described class of heparin-dependent Abs found in ~25% of patients exposed to protamine and heparin during cardiopulmonary bypass surgery (CPB). ...
Full textCite
ConferenceBlood · November 16, 2012
AbstractAbstract 3344INTRO:Protamine (PRT) is routinely used to reverse heparin (H) anticoagulation d ...
Full textCite
ConferenceBlood · November 16, 2012
AbstractAbstract 2204Electrostatic interactions between Platelet factor 4 (PF4), a cationic protein, and heparin, an anionic carbohydrate result in the formation of ultra-lar ...
Full textCite
ConferenceBlood · November 16, 2012
AbstractAbstract 269Mice injected with ultra-large complexes (ULCs) of platelet factor-4 (PF4) and heparin (PF4/H) exhibit a strong immune response which mimics that seen in ...
Full textCite